Two Sigma Advisers
RBOT

Two Sigma Advisers’s Vicarious Surgical RBOT Stock Holding History

Two Sigma Advisers’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,830
Closed -$31.1K – 2601
2023
Q4 		$31.1K Buy
+2,830
New +$31.5K ﹤0.01% 2429

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's RBOT Position: Q1 2024 in Review

Two Sigma Advisers sold out of Vicarious Surgical (RBOT) in Q1 2024, closing a stake of 2,830 shares — an estimated $31.1K sold.

Two Sigma Advisers first reported a position in RBOT in Q4 2023 and held it in 1 quarter. The position peaked at $31.1K in Q4 2023. 72 funds tracked by Wall St. Rank hold RBOT as of Q1 2024.

  • Two Sigma Advisers reported no remaining Vicarious Surgical position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 2,830 Vicarious Surgical shares in Q1 2024, an estimated $31.1K.
  • Two Sigma Advisers first reported a position in Vicarious Surgical in Q4 2023 and held it in 1 quarter.
  • Two Sigma Advisers's Vicarious Surgical position peaked at $31.1K in Q4 2023.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.